Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated with Immunotherapy

Pseudoprogression has been observed in patients with various tumor types treated with immunotherapy. However, the frequency of pseudoprogression is unknown in gastrointestinal malignancies. Metastatic colorectal cancer (mCRC) and advanced pancreatic ductal adenocarcinoma (PDAC) patients who progress...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother
Main Authors: Parseghian, Christine M., Patnana, Madhavi, Bhosale, Priya, Hess, Kenneth R., Shih, Ya-Chen Tina, Kim, Bumyang, Kopetz, Scott, Overman, Michael J., Varadhachary, Gauri R., Javle, Milind, Naing, Aung, Piha-Paul, Sarina, Hong, David, Le, Hung, Subbiah, Vivek, Pant, Shubham
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028046/
https://ncbi.nlm.nih.gov/pubmed/29668571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000222
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados